Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Not Just J&J’s Problem: The Evolving Talc Litigation Landscape

This article is powered by The Rose Sheet

Executive Summary

Legal experts see cosmetic talc suits flaring along two tracks – either alleging the carcinogenicity of talc itself or linking cancer cases to asbestos-tainted talc sources. At least one attorney sees the latter as a potentially bigger threat to the cosmetics industry with the traditional pool of asbestos defendants drying up.


Related Content

Colgate's Ups, Downs In Bicoastal Fight Against Talc Mesothelioma Suits
J&J Wins Reversal Of $72M Talc Verdict, Signaling Whole New Ballgame
J&J Slammed With Costliest Talc Verdict Yet; California Plaintiff Awarded $417M
Rep. Pallone Seeks Answers In Tween Makeup Asbestos Controversy
FDA Research Seeks Better Understanding Of Talc’s Potential Cancer Link
Honest Recalls Baby Powder Due To Possible Contamination
J&J To Put Johnson’s Bedtime Dispute To Rest With $5m Settlement
2016 In Review: FDA Transparency, Claims Enforcement A One-Off?
Cosmetic News In Brief: J&J Incurs Third Talc Trial Loss; Lauder Acquires BECCA; More
J&J Talc Suit Dismissals: Plaintiffs Lack Causation Thread For Proof Quilt


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts